ImmunityBio reports $113 million revenue, 700% annual increase
Go back to ImmunityBio reports $113 million revenue, 700% annual increase| (NASDAQ: IBRX) | Delayed: 7.25 +0.30 (4.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.95 | 52 Week High | $ | |||
| Open | $6.96 | 52 Week Low | $ | |||
| Day High | $7.41 | P/E | N/A | |||
| Day Low | $6.94 | EPS | $ | |||
| Volume | 11,496,600 | |||||

